These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

267 related items for PubMed ID: 22137887

  • 1. Autoantibodies in primary Sjögren's syndrome patients induce internalization of muscarinic type 3 receptors.
    Jin M, Hwang SM, Davies AJ, Shin Y, Bae JS, Lee JH, Lee EB, Song YW, Park K.
    Biochim Biophys Acta; 2012 Feb; 1822(2):161-7. PubMed ID: 22137887
    [Abstract] [Full Text] [Related]

  • 2. Effect of Antimuscarinic Autoantibodies in Primary Sjögren's Syndrome.
    Kim N, Shin Y, Choi S, Namkoong E, Kim M, Lee J, Song Y, Park K.
    J Dent Res; 2015 May; 94(5):722-8. PubMed ID: 25784251
    [Abstract] [Full Text] [Related]

  • 3. Functional epitope of muscarinic type 3 receptor which interacts with autoantibodies from Sjogren's syndrome patients.
    Koo NY, Li J, Hwang SM, Choi SY, Lee SJ, Oh SB, Kim JS, Lee EB, Song YW, Park K.
    Rheumatology (Oxford); 2008 Jun; 47(6):828-33. PubMed ID: 18400835
    [Abstract] [Full Text] [Related]

  • 4. Effect of anti-muscarinic autoantibodies on leukocyte function in Sjögren's syndrome.
    Namkoong E, Lee SW, Kim N, Choi Y, Park K.
    Mol Immunol; 2017 Oct; 90():136-142. PubMed ID: 28750255
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Inhibitory effects of autoantibodies on the muscarinic receptors in Sjögren's syndrome.
    Li J, Ha YM, Kü NY, Choi SY, Lee SJ, Oh SB, Kim JS, Lee JH, Lee EB, Song YW, Park K.
    Lab Invest; 2004 Nov; 84(11):1430-8. PubMed ID: 15448705
    [Abstract] [Full Text] [Related]

  • 8. Autoantibodies in Sjögren's syndrome patients acutely inhibit muscarinic receptor function.
    Jin M, Hwang SM, Koo NY, Kim B, Kho HS, Choi SY, Song YW, Park K.
    Oral Dis; 2012 Mar; 18(2):132-9. PubMed ID: 21899666
    [Abstract] [Full Text] [Related]

  • 9. Inhibitory effects of muscarinic receptor autoantibodies on parasympathetic neurotransmission in Sjögren's syndrome.
    Waterman SA, Gordon TP, Rischmueller M.
    Arthritis Rheum; 2000 Jul; 43(7):1647-54. PubMed ID: 10902771
    [Abstract] [Full Text] [Related]

  • 10. Younger patients with primary Sjögren's syndrome are more likely to have salivary IgG anti-muscarinic acetylcholine receptor type 3 antibodies.
    Jayakanthan K, Ramya J, Mandal SK, Sandhya P, Gowri M, Danda D.
    Clin Rheumatol; 2016 Mar; 35(3):657-62. PubMed ID: 26809799
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. New epitopes and function of anti-M3 muscarinic acetylcholine receptor antibodies in patients with Sjögren's syndrome.
    Tsuboi H, Matsumoto I, Wakamatsu E, Nakamura Y, Iizuka M, Hayashi T, Goto D, Ito S, Sumida T.
    Clin Exp Immunol; 2010 Oct; 162(1):53-61. PubMed ID: 20731676
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Up-regulation of M3-muscarinic receptors in labial salivary gland acini in primary Sjögren's syndrome.
    Beroukas D, Goodfellow R, Hiscock J, Jonsson R, Gordon TP, Waterman SA.
    Lab Invest; 2002 Feb; 82(2):203-10. PubMed ID: 11850533
    [Abstract] [Full Text] [Related]

  • 15. Antimuscarinic antibodies in primary Sjögren's syndrome reversibly inhibit the mechanism of fluid secretion by human submandibular salivary acinar cells.
    Dawson LJ, Stanbury J, Venn N, Hasdimir B, Rogers SN, Smith PM.
    Arthritis Rheum; 2006 Apr; 54(4):1165-73. PubMed ID: 16572451
    [Abstract] [Full Text] [Related]

  • 16. The role of muscarinic acetylcholine receptor type 3 polypeptide (M3RP205-220) antibody in the saliva of patients with primary Sjögren's syndrome.
    He J, Qiang L, Ding Y, Wei P, Li YN, Hua H, Li ZG.
    Clin Exp Rheumatol; 2012 Apr; 30(3):322-6. PubMed ID: 22510450
    [Abstract] [Full Text] [Related]

  • 17. M3 muscarinic acetylcholine receptor-reactive Th17 cells in primary Sjögren's syndrome.
    Abe S, Tsuboi H, Kudo H, Asashima H, Ono Y, Honda F, Takahashi H, Yagishita M, Hagiwara S, Kondo Y, Matsumoto I, Sumida T.
    JCI Insight; 2020 Aug 06; 5(15):. PubMed ID: 32614803
    [Abstract] [Full Text] [Related]

  • 18. Muscarinic acetylcholine type-3 receptor desensitization due to chronic exposure to Sjögren's syndrome-associated autoantibodies.
    Cha S, Singson E, Cornelius J, Yagna JP, Knot HJ, Peck AB.
    J Rheumatol; 2006 Feb 06; 33(2):296-306. PubMed ID: 16465661
    [Abstract] [Full Text] [Related]

  • 19. [Analysis of epitopes and function of anti-M3 muscarinic acetylcholine receptor antibodies in patients with Sjögren's syndrome].
    Tsuboi H, Matsuo N, Iizuka M, Nakamura Y, Matsumoto I, Sumida T.
    Nihon Rinsho Meneki Gakkai Kaishi; 2010 Feb 06; 33(4):222-8. PubMed ID: 20818151
    [Abstract] [Full Text] [Related]

  • 20. Passive transfer of Sjogren's syndrome IgG produces the pathophysiology of overactive bladder.
    Wang F, Jackson MW, Maughan V, Cavill D, Smith AJ, Waterman SA, Gordon TP.
    Arthritis Rheum; 2004 Nov 06; 50(11):3637-45. PubMed ID: 15529387
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.